| __timestamp | Pfizer Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 14097000000 | 91733000 |
| Thursday, January 1, 2015 | 14809000000 | 87644000 |
| Friday, January 1, 2016 | 14837000000 | 92365000 |
| Sunday, January 1, 2017 | 14784000000 | 85656000 |
| Monday, January 1, 2018 | 14455000000 | 88196000 |
| Tuesday, January 1, 2019 | 14350000000 | 89971000 |
| Wednesday, January 1, 2020 | 11615000000 | 93413000 |
| Friday, January 1, 2021 | 12703000000 | 91355000 |
| Saturday, January 1, 2022 | 13677000000 | 113676000 |
| Sunday, January 1, 2023 | 14771000000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
Unleashing insights
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Pfizer Inc. and Taro Pharmaceutical Industries Ltd. have showcased contrasting strategies in this domain. From 2014 to 2023, Pfizer's SG&A expenses fluctuated, peaking in 2016 and 2023, with a notable dip in 2020. This reflects a strategic shift, possibly due to restructuring or market conditions. In contrast, Taro's SG&A costs remained relatively stable, with a significant increase in 2023, suggesting a potential expansion or increased operational costs.
Pfizer's expenses are approximately 150 times higher than Taro's, highlighting the scale difference between the two. However, Taro's recent surge in SG&A expenses, nearly doubling from 2022 to 2023, indicates a dynamic change in their operational strategy. Missing data for 2024 suggests ongoing developments worth monitoring.
Cost Management Insights: SG&A Expenses for AbbVie Inc. and Pfizer Inc.
Selling, General, and Administrative Costs: Pfizer Inc. vs GSK plc
Selling, General, and Administrative Costs: Pfizer Inc. vs Axsome Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Pfizer Inc. or Catalyst Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Pfizer Inc. and MannKind Corporation
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Amphastar Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.